The collected and future blood samples

are to be analyzed for the following biological markers
at the following laboratories:


1. selected plasma proteins Abbott, Chicago (Center of Excellence, Amsterdam)
2. serum cathepsin Institute of Pharmacology, University of Ljubljana,Slovenia
3. elected plasma proteins EDP Biosciences, Knoxville, TN, USA
4. tumor-derived DNA mutations Clinical Genomics, Bridgewater, NJ, USA
5. (◊) tumor-derived DNA methylations Aarhus University, Skejby Hospital
 6. selected plasma proteins Fred Hutchinson Cancer Research Center, Seattle, WA, USA
 7. selected nucleosomes, histone modifications VolitionRX, Isnes, Belgium
 8. selected plasma proteins Applied Proteomics, San Diego, CA, USA
 9. serum metabolomes ChemImage Inc., Pittsburgh, PA, USA
 10. galectin-3 analytes MD Anderseon Cancer Center, Houston, TX, USA
 11. YKL-40 Oncological Laboratory, Herlev Hospital

(◊)     This specific part of the entire project is sponsored by The Danish Strategic Research Council (19,9 mio. DKK)
in collaboration with Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA; and University College London.




Read more:






Current Research      Protocol Outlines

Screening-research History

Print Friendly, PDF & Email


ColoRectal Cancer Research

Gastroenheden, Hvidovre Hospital

Kettegård Allé 30

2650 Hvidovre